Literature DB >> 19871374

PARA-AMINOBENZOIC ACID PRODUCTION BY STAPHYLOCOCCI.

W W Spink1, L D Wright, J J Vivino, H R Skeggs.   

Abstract

1. Strains of staphylococci produce diazotizable materials which can be converted to a dye, and the intensity of the color reaction can be quantitated in the same manner as p-aminobenzoic acid. The sulfonamide-resistant strains which we have studied produce more diazotizable substance than non-resistant strains. 2. The development of a color by the diazotizable substance can be inhibited by exposing the substance to a soil bacillus (Mirick) specifically adapted to oxidize PABA. 3. The diazotizable substance produced by staphylococci inhibits the anti-staphylococcic action of sodium sulfathiazole to approximately the same degree as equivalent amounts of pure p-aminobenzoic acid. 4. Two microbiological methods for assaying p-aminobenzoic acid were employed for quantitating the amount of this material produced by staphylococci. In general, the sulfonamide-resistant strains produced more p-aminobenzoic acid than the sulfonamide-sensitive strains. The inconstant results obtained with these biological assays are discussed.

Entities:  

Year:  1944        PMID: 19871374      PMCID: PMC2135388          DOI: 10.1084/jem.79.4.331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  INCREASED SYNTHESIS OF p-AMINOBENZOIC ACID ASSOCIATED WITH THE DEVELOPMENT OF SULFONAMIDE RESISTANCE IN STAPHYLOCOCCUS AUREUS.

Authors:  M Landy; N W Larkum; E J Oswald; F Streightoff
Journal:  Science       Date:  1943-03-19       Impact factor: 47.728

2.  THE OXIDATION OF p-AMINOBENZOIC ACID AND ANTHRANILIC ACID BY SPECIFICALLY ADAPTED ENZYMES OF A SOIL BACILLUS.

Authors:  G S Mirick
Journal:  J Exp Med       Date:  1943-10-01       Impact factor: 14.307

3.  THE INHIBITION OF THE BACTERIOSTATIC ACTION OF SULFONAMIDE DRUGS BY SUBSTANCES OF ANIMAL AND BACTERIAL ORIGIN.

Authors:  C M Macleod
Journal:  J Exp Med       Date:  1940-08-31       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.